Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,177-1,188 of 4,306
Drug study icon
CompletedNCT01182727

Salsalate for Insulin Resistance in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Other study type icon
CompletedNCT02118571

Schizophrenia Cognition Scale Development

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 55 Years
Countries
United States
Sponsor
Carelon Research
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05339347

Schizophrenia Treatment With Photoneuromodulation

This summary needs review. Please check the official study record and contact the research team for details.

In São Paulo
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
Brazil
Sponsor
University of Sao Paulo
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02660775

Social Cognitive Assessment in Autism and Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bron
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 45 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
Other study type icon
CompletedNCT05273164

State Representation in Early Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 15 Years to 45 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Device study icon
CompletedNCT05664594

State Representation in Early Psychosis - Project 4

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 15 Years to 45 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Drug study icon
CompletedNCT00001258

Studies of Frontal Lobe Brain Functioning in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bethesda
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 90 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Drug study icon
CompletedNCT04325737

Safety study of SEP-363856 in schizophrenia

This study is completed in Japan. It is testing SEP-363856 for schizophrenia.

Multiple locations, including Omuta-shi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Japan
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
Drug study icon
CompletedNCT03370640

Safety study of SEP-363856 in schizophrenia

This study is completed in Japan. It is testing SEP-363856 for schizophrenia.

Multiple locations, including Kōnan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Japan
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.